Skip to main content
SpringerLink
Log in
Book cover

Cancer Epidemiology pp 51–64Cite as

Breast Cancer in Asia

  • Protocol

Part of the book series: Methods in Molecular Biology ((MIMB,volume 471))

Summary

Breast cancer is the commonest cancer in most countries in Asia. The incidence rates remain low, although increasing at a more rapid rate than in western countries, due to changes in the lifestyle and diet. There are many differences between breast cancer in Asia compared with western countries. The mean age at onset is younger than in the west, and unlike the west, the age-specific incidence decreases after the age of 50 years. Because there is no population-based breast cancer screening program in the majority of Asian countries, the majority of patients present with advanced disease. There is a higher proportion of hormone receptor-negative patients, and some evidence that the cancers in Asia are of a higher grade. Most of the Asian countries are low- and middle-income countries, where access to effective care is limited. Because of the late detection and inadequate access to care, survival of women with breast cancer in Asia is lower than in western countries. Improving breast health in most of the Asian countries remains a challenge that may be overcome with collaboration from multiple sectors, both public and private.

This is a preview of subscription content, log in via an institution.

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Parkin DM, Whelan SL, Ferlay J, Storm H (2005) Cancer incidence in five continents, volumes I–VIII. IARC CancerBase no. 6. IARC Press, Lyon, France (http://www-dep.iarc.fr).

    Google Scholar 

  2. Seow A, Duffy SW, McGee MA, Lee J, Lee HP. (1996). Breast cancer in Singapore: trends in incidence 1965–1992. Int J Epidemiol25, 40–5.

    Article  CAS  PubMed  Google Scholar 

  3. Yang BH, Parkin DM, Cai L, Zhang ZF. (2004). Cancer burden and trends in the Asian Pacific Rim Region. Asian Pac. J Cancer Prev5, 96–117.

    PubMed  Google Scholar 

  4. Ziegler RG, Hoover RN, Pike MC, et al. (1993). Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst85, 1819–27.

    Article  CAS  PubMed  Google Scholar 

  5. Bray F, McCarron P, Parkin DM. (2004). The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6, 229–39.

    Article  PubMed  Google Scholar 

  6. Lim GCC, Halimah Y (eds). (2004). Cancer incidence in Malaysia 2003. National Cancer Registry, Kuala Lumpur, Malaysia.

    Google Scholar 

  7. Yip CH, Taib NA, Mohamed I. (2006). Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev7, 369–74.

    PubMed  Google Scholar 

  8. Son BH, Kwak BS, Kim JK, et al. (2006). Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years. Arch Surg141, 155–60.

    Article  PubMed  Google Scholar 

  9. Henderson BE, Ross R, Bernstein L. (1988). Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res48, 246–53.

    CAS  PubMed  Google Scholar 

  10. Moolgavkar SH, Stevens RG, Lee JA. (1979). Effect of age on incidence of breast cancer in females. J Natl Cancer Inst62, 493–501

    CAS  PubMed  Google Scholar 

  11. 1 1. Minami Y, Tsubono Y, Nishima Y, Ohuchi N, Shibuya D, Hisamichi S. (2004). The increase in female breast cancer incidence in Japan: emergence of a birth cohort effect. Int J Cancer108, 901–6.

    Article  CAS  PubMed  Google Scholar 

  12. Yoshimoto M, Tada K, Hori H, et al. (2004). Improvement in the prognosis of Japanese breast cancer patients from 1946–2001: an institutional review. Jpn J Clin Oncol34, 457–62.

    Article  PubMed  Google Scholar 

  13. Hisham AN, Yip CH. (2003). Spectrum of breast cancer in Malaysian women: an overview. World J Surg27, 921–23.

    Article  PubMed  Google Scholar 

  14. Aggarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS. (2007). Spectrum of breast cancer in Asian women. World J Surg31, 1031–40.

    Article  PubMed  Google Scholar 

  15. Remenick L. (2006). The challenge of early breast cancer detection among immigrant and minority women in multicultural societis. Breast J12, S103–S110.

    Article  Google Scholar 

  16. Parsa P, Kandiah M, Abdul Rahman H, Mohd Zulkefli NA. (2006). Barriers for breast cancer screening among Asian women: a mini literature review. Asian Pac J Cancer Prev7, 509–14.

    PubMed  Google Scholar 

  17. Hebert JR, Ghumare SS, Gupta PC. (2006). Stage at diagnosis and relative differences in breast and prostate cancer incidence in India: comparison with the United States. Asian Pac J Cancer Prev7, 547–55.

    PubMed  Google Scholar 

  18. Al-Moundhari M, Al-Bahrani B, Pervez J, et al. (2004). The outcome of treatment of breast cancer in a developing country–Oman. Breast13, 139–45.

    Article  Google Scholar 

  19. Vahdaninia1 M, Montazeri A. (2004). Breast cancer in Iran: a survival analysis. Asian Pac J Cancer Prev5, 223–25.

    PubMed  Google Scholar 

  20. Ahn SH, Yoo KY. (2006). The Korean Breast Cancer Society. Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996–2004. Breast Cancer Res Treat99, 209–14.

    Article  PubMed  Google Scholar 

  21. 21.Tan EY, Wong HB, Ang BK, Chan MY. (2005). Locally advanced and metastatic breast cancer in a tertiary hospital. Ann Acad Med Singap34, 595–601.

    CAS  PubMed  Google Scholar 

  22. 22..Klonoff-Cohen HS, Schaffroth LB, Edel-stein SL, Molgaard C, Saltzstein SL. (1998). Breast cancer histology in Caucasians, African Americans, Hispanics, Asians and PacificIs-landers. Ethn Health3, 189–98.

    Article  CAS  PubMed  Google Scholar 

  23. Sakamoto G, Sugano H. (1991). Pathology of breast cancer: present and prospect in Japan. Breast Cancer Res Treat18, S581–S583.

    Article  Google Scholar 

  24. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. (2004). Breast cancer in Iran: results of a multicentre study. Asia Pac J Cancer Prev 5, 24–7.

    Google Scholar 

  25. CH Yip, LM Looi. (1996). Breast cancer in Malaysian women–pathological features and treatment. Asian J Surg 19, 112.

    Google Scholar 

  26. Gapstur SM, Dupuis J, Gann P, Collila S, Winchester DP. (1996). Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic white women. An analysis of 13,239 cases. Cancer 77, 1465–71.

    Article  CAS  PubMed  Google Scholar 

  27. Li CI Malone KE, Daling JR. (2002). Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 11, 601–7.

    Google Scholar 

  28. Desai SB, Moonim MT, Gill AK, Punia RS, Naresh KN, Chinoy RF. (2000) Hormone receptor status of breast cancer in India: a study of 798 tumours. Breast 9, 267–70.

    Article  CAS  PubMed  Google Scholar 

  29. 29.Navani S, Bhaduri AS. (2005). High incidence of oestrogen receptor negative progesterone receptor positive phenotype in Indian breast cancer: fact or fiction? Indian J Pathol Microbiol 48, 199–201.

    PubMed  Google Scholar 

  30. Aryandono T, Harijadi, Soeripto. (2006). Hormone receptor status of operable breast cancer patients in Indonesia: correlation with other prognostic factors and survival. Asian Pac J Cancer Prev 7, 321–4.

    PubMed  Google Scholar 

  31. 31.Sughayer MA, Al-Khawaja MM, Massarweh S, Al-Masri M. (2006). Prevalence of hormone receptors and HE2/neu in breast cancer cases in Jordan. Pathol Oncol Res 12, 83–6.

    Article  CAS  PubMed  Google Scholar 

  32. Chow LW, Ho P. (2000). Hormonal receptor determination of 1,052 Chinese breast cancers. J Surg Oncol 75, 172–5.

    Article  CAS  PubMed  Google Scholar 

  33. Li CI, Daling JR, Malone KE. (2003). Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 21, 28–34.

    Article  CAS  PubMed  Google Scholar 

  34. Pujol P, Hilsenbeck SG, Chamness GC, Elledge RM. (1994). Rising levels of estrogen receptor in breast cancer over 2 decades. Cancer 74, 1601–6.

    Article  CAS  PubMed  Google Scholar 

  35. Bloom HJG, Richardson WW. (1957) His-tological grading and prognosis in breast cancer. Br J Cancer 11, 359–77.

    CAS  PubMed  Google Scholar 

  36. Elston CW, Ellis IO. (2002). Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 41, 154–61.

    Article  CAS  PubMed  Google Scholar 

  37. Aryandono T, Harijadi, Soeripto. (2006). Survival from operable breast cancer: p r ognostic factors in Yogyakarta, Indonesia. Asian Pac J Cancer Prev6, 455–9.

    Google Scholar 

  38. Zhang T, Tu X, Xu W. (1998). A study of prognostic factors in breast cancer: histological grading. Zhong Hua Bing Li Xue Za Zhi27, 405–7

    CAS  Google Scholar 

  39. Meyer JS, Alvarez C, Milikowski C, et al. (2005). Breast carcinoma malignancy grading by Bloom—Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index. Mod Pathol18, 1067–78.

    Article  PubMed  Google Scholar 

  40. 40 Sikka M, Agarwal S, Bhatia A. (1999). Interobserver agreement of the Nottingham histologic grading scheme for infiltrating duct carcinoma breast. Indian J Cancer36, 149–53.

    CAS  PubMed  Google Scholar 

  41. Menard S, Taqliabue E, Campiqlio M, Pupa SM. (2000). Role of HER2 gene overepression in breast carcinoma. J Cell Physiol182, 150–62.

    Article  CAS  PubMed  Google Scholar 

  42. Homael-Shandiz F, Ghavam-Nassiri MR, Sharif N, et al. (2006). Evaluation of the relationship between human epidermal growth factor receptor-2/neu (c-erbB-2) amplification and pathologic grading in patients with breast cancer. Saudi Med J27, 1810–4.

    Google Scholar 

  43. Cianfrocca M, Goldstein LJ. (2004). Prognostic and predictive factors in early stage breast cancer. Oncologist9, 606–16.

    Article  PubMed  Google Scholar 

  44. Sankaranarayanan R, Swaminathan R, Black RJ. (1996). Global variations in cancer survival. Cancer8, 2461–4.

    Article  Google Scholar 

  45. Pal SK, Mittal B. (2004). Fight against cancer in countries with limited resources: the post-genomic era scenario. Asian Pac J Cancer Prev5, 328–33.

    PubMed  Google Scholar 

  46. Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global cancer statistics, 2002. CA Cancer J Clin55, 74–108.

    Article  PubMed  Google Scholar 

  47. Moore MA, Kazuo T, Pham Hoang Anh, et al. (2003). Grand challenges in global health and the practical prevention program? Asian focus on cancer prevention in females of the developing world. Asian Pac J Cancer Prev4, 153–65.

    PubMed  Google Scholar 

  48. Shapiro S, Venet W, Strax P, et al. (1988). Periodic screening for breast cancer: the Health Insurance Plan project and its sequelae, 1963–1986. Johns Hopkins University Press, Baltimore, MD.

    Google Scholar 

  49. Nystrom Lrutqvist LE, Wall S, et al. (1993). Breast screening with mammography: overview of the Swedish Randomized Trials. Lancet17, 973–8.

    Article  Google Scholar 

  50. Roberts MM, Alexander FE, Anderson TJ, et al. (1990) Edinburgh trial of screening for breast cancer: mortality at 7 years. Lancet335, 241–6.

    Article  CAS  PubMed  Google Scholar 

  51. Andersson I, Aspergren K, Janzon L, et al. (1988). Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ297, 943–8.

    Article  CAS  PubMed  Google Scholar 

  52. Frisell J, Eklund G, Hellstrom L, et al. (1991). Randomized study of mammography screening-preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat18, 49–56.

    Article  CAS  PubMed  Google Scholar 

  53. Miller AB, To T, Baines CJ, Wall C. (2002). The Canadian National Breast Screening Study 1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women aged 40–49 years. Ann Intern Med137, 305–12.

    PubMed  Google Scholar 

  54. Ng EH, Ng FH, Tan PH, Low SC, Chiang G, et al. (1998). Results of intermediate measures from a population based randomized trial of mammographic screening-prevalence and detection of breast carcinoma among Asian women. Cancer82, 1521–8.

    Article  CAS  PubMed  Google Scholar 

  55. Leung GM, Lam TH, Thach TQ, Hedley AJ. (2002). Will screening mammography in the east do more harm than good? Am J Public Health92, 1841–6.

    Article  PubMed  Google Scholar 

  56. Hill D, White V, Jolley D, Mapperson K. (1988). Self examination of the breast: is it beneficial? A meta-analysis of studies investigating breast self-examination and extent of disease in patients with breast cancer. BMJ297, 271–5.

    Article  CAS  PubMed  Google Scholar 

  57. Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, et al. (2002). Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst94, 1445–57.

    PubMed  Google Scholar 

  58. Hackshaw AK, Paul EA. (2003). Breast Self examination and death from breast cancer: a meta-analysis. Br J Cancer88, 1047–53.

    Article  CAS  PubMed  Google Scholar 

  59. Bancej C, Decker K, Chiarelli A, Harrison M, Turner D, Brisson J. (2003). Contribution of CBE to mammography screening in the early detection of breast cancer. J Med Screen10, 16–21.

    Article  CAS  PubMed  Google Scholar 

  60. Oestreicher N, White E, Lehman CD, Man-delson MT, Porter PL, Taplin SH. (2002). Predictors of sensitivity of CBE. Breast Cancer Res Treat76, 73–81.

    Article  CAS  PubMed  Google Scholar 

  61. Weiss NS. (2003). Breast cancer mortality in relation to CBE and BSE. Breast J9, S86–S89

    Article  PubMed  Google Scholar 

  62. Pisani P, Parkin DM, Ngelangel C, Esteban D, et al. (2006). Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer118, 149–54.

    Article  CAS  PubMed  Google Scholar 

  63. Parisa P, Kandiah M, Abdul Rahman H, Mohd Zulkefli NA. (2006). Barriers to breast cancer screening among Asian women: a mini literature review. Asian Pac J Cancer Prev7, 509–514.

    Google Scholar 

  64. Varun G. (2001). Are incentives everything? Payment mechanisms for health care providers in developing countries. World Bank Policy Research Working Paper No. 2624. (http://ssrn.com/abstract=632692)

  65. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ. (2005). Meeting highlights: international expert consensus on the primary therapy of early breast cancer. Ann Oncol16, 1569–83.

    Article  CAS  PubMed  Google Scholar 

  66. Carlson RW, Anderson BO, Burstein HJ, Cox CE, Edge SB, Farrar WB, et al. (2005) Breast cancer. J Natl Compr Canc Netw3, 238–89.

    PubMed  Google Scholar 

  67. World Health Organization. (2002). Executive summary of the national cancer control programmes: policies and managerial guidelines. World Health Organization, Geneva, Switzerland.

    Google Scholar 

  68. Smith RA, Caleffi M, Albert US, Chen TH, Duffy SW, Franceschi D, et al. (2006). Breast cancer in limited-resource countries: early detection and access to care. Breast J 12, S16–S26.

    Article  PubMed  Google Scholar 

  69. Shyyan R, Masood S, Badwe RA, Errico KM, Liberman L, Ozmen V, et al. (2006). Breast cancer in limited-resource countries: diagnosis and pathology. Breast J 12, S27–S37.

    Article  PubMed  Google Scholar 

  70. Eniu A, Carlson RW, Aziz Z, Bines J, Hortobagyi GN, Bese NS, et al. (2006). Breast cancer in limited-resource countries: treatment and allocation of resources. Breast J12, S38–S53.

    Article  PubMed  Google Scholar 

  71. Anderson BO, Yip CH, Ramsey SD, Bengoa R, Braun S, Fitch M, et al. (2006). Breast cancer in limited-resource countries: health care systems and public policy. Breast J12, S54–S69.

    Article  PubMed  Google Scholar 

  72. Anderson BO, Shyyan R, Eniu A, Smith RA, Yip CH, Bese NS, et al. (2006). Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J12., S3–S15.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University Malaya, Medical Centre, Kuala Lumpur, Malaysia

    Cheng-Har Yip

Authors
  1. Cheng-Har Yip
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Cancer Control and Population Sciences Bethesda, Maryland, 20892, USA

    Mukesh Verma PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Yip, CH. (2009). Breast Cancer in Asia. In: Verma, M. (eds) Cancer Epidemiology. Methods in Molecular Biology, vol 471. Humana Press. https://doi.org/10.1007/978-1-59745-416-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-416-2_3

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-987-1

  • Online ISBN: 978-1-59745-416-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation